Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP548550.RAgc_lUBiC5249YVQ3adslcJzbcGz5hN0yj7pEHDib75M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP548550.RAgc_lUBiC5249YVQ3adslcJzbcGz5hN0yj7pEHDib75M130_assertion type Assertion NP548550.RAgc_lUBiC5249YVQ3adslcJzbcGz5hN0yj7pEHDib75M130_head.
- NP548550.RAgc_lUBiC5249YVQ3adslcJzbcGz5hN0yj7pEHDib75M130_assertion description "[RNA interference targeting at p65 increased the sensitivity of the ESCC cell lines to 5-fluorouracil, suggesting that NF-kappaB might be a good target for cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548550.RAgc_lUBiC5249YVQ3adslcJzbcGz5hN0yj7pEHDib75M130_provenance.
- NP548550.RAgc_lUBiC5249YVQ3adslcJzbcGz5hN0yj7pEHDib75M130_assertion evidence source_evidence_literature NP548550.RAgc_lUBiC5249YVQ3adslcJzbcGz5hN0yj7pEHDib75M130_provenance.
- NP548550.RAgc_lUBiC5249YVQ3adslcJzbcGz5hN0yj7pEHDib75M130_assertion SIO_000772 16680372 NP548550.RAgc_lUBiC5249YVQ3adslcJzbcGz5hN0yj7pEHDib75M130_provenance.
- NP548550.RAgc_lUBiC5249YVQ3adslcJzbcGz5hN0yj7pEHDib75M130_assertion wasDerivedFrom befree-2016 NP548550.RAgc_lUBiC5249YVQ3adslcJzbcGz5hN0yj7pEHDib75M130_provenance.
- NP548550.RAgc_lUBiC5249YVQ3adslcJzbcGz5hN0yj7pEHDib75M130_assertion wasGeneratedBy ECO_0000203 NP548550.RAgc_lUBiC5249YVQ3adslcJzbcGz5hN0yj7pEHDib75M130_provenance.